Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Observation of electron-antineutrino disappearance at Daya Bay.
An FP, Bai JZ, Balantekin AB, Band HR, Beavis D, Beriguete W, Bishai M, Blyth S, Boddy K, Brown RL, Cai B, Cao GF, Cao J, Carr R, Chan WT, Chang JF, Chang Y, Chasman C, Chen HS, Chen HY, Chen SJ, Chen SM, Chen XC, Chen XH, Chen XS, Chen Y, Chen YX, Cherwinka JJ, Chu MC, Cummings JP, Deng ZY, Ding YY, Diwan MV, Dong L, Draeger E, Du XF, Dwyer DA, Edwards WR, Ely SR, Fang SD, Fu JY, Fu ZW, Ge LQ, Ghazikhanian V, Gill RL, Goett J, Gonchar M, Gong GH, Gong H, Gornushkin YA, Greenler LS, Gu WQ, Guan MY, Guo XH, Hackenburg RW, Hahn RL, Hans S, He M, He Q, He WS, Heeger KM, Heng YK, Hinrichs P, Ho TH, Hor YK, Hsiung YB, Hu BZ, Hu T, Hu T, Huang HX, Huang HZ, Huang PW, Huang X, Huang XT, Huber P, Isvan Z, Jaffe DE, Jetter S, Ji XL, Ji XP, Jiang HJ, Jiang WQ, Jiao JB, Johnson RA, Kang L, Kettell SH, Kramer M, Kwan KK, Kwok MW, Kwok T, Lai CY, Lai WC, Lai WH, Lau K, Lebanowski L, Lee J, Lee MK, Leitner R, Leung JK, Leung KY, Lewis CA, Li B, Li F, Li GS, Li J, Li QJ, Li SF, Li WD, Li XB, Li XN, Li XQ, Li Y, Li ZB, Liang H, Liang J, Lin CJ, Lin GL, Lin SK, Lin SX, Lin YC, Ling JJ, Link JM, Littenberg L, Littlejohn BR, Liu BJ, Liu C, Liu DW, Liu H, Liu JC, Liu JL, Liu S, Liu X, Liu YB, Lu C, L… See abstract for full author list ➔ An FP, et al. Among authors: oh d. Phys Rev Lett. 2012 Apr 27;108(17):171803. doi: 10.1103/PhysRevLett.108.171803. Epub 2012 Apr 23. Phys Rev Lett. 2012. PMID: 22680853 Free article.
Structural distortions in metal clusters.
Yi JY, Oh DJ, Bernholc J. Yi JY, et al. Phys Rev Lett. 1991 Sep 16;67(12):1594-1597. doi: 10.1103/PhysRevLett.67.1594. Phys Rev Lett. 1991. PMID: 10044195 No abstract available.
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Oh DY, He AR, Bouattour M, Okusaka T, Qin S, Chen LT, Kitano M, Lee CK, Kim JW, Chen MH, Suksombooncharoen T, Ikeda M, Lee MA, Chen JS, Potemski P, Burris HA 3rd, Ostwal V, Tanasanvimon S, Morizane C, Zaucha RE, McNamara MG, Avallone A, Cundom JE, Breder V, Tan B, Shimizu S, Tougeron D, Evesque L, Petrova M, Zhen DB, Gillmore R, Gupta VG, Dayyani F, Park JO, Buchschacher GL Jr, Rey F, Kim H, Wang J, Morgan C, Rokutanda N, Żotkiewicz M, Vogel A, Valle JW. Oh DY, et al. Lancet Gastroenterol Hepatol. 2024 May 29:S2468-1253(24)00095-5. doi: 10.1016/S2468-1253(24)00095-5. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38823398
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ, Oh DY, Kato K, Arkenau T, Tabernero J, Correa MC, Zimina AV, Bai Y, Shi J, Lee KW, Wang J, Poddubskaya E, Pan H, Rha SY, Zhang R, Hirano H, Spigel D, Yamaguchi K, Chao Y, Wyrwicz L, Disel U, Cid RP, Fornaro L, Evesque L, Wang H, Xu Y, Li J, Sheng T, Yang S, Li L, Moehler M, Xu RH; RATIONALE-305 Investigators. Qiu MZ, et al. Among authors: oh dy. BMJ. 2024 May 28;385:e078876. doi: 10.1136/bmj-2023-078876. BMJ. 2024. PMID: 38806195 Clinical Trial.
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Grivas P, Garralda E, Meric-Bernstam F, Mellinghoff IK, Goyal L, Harding JJ, Dees EC, Bahleda R, Azad NS, Karippot A, Kurzrock R, Tabernero J, Kononen J, Ng MCH, Mehta R, Uboha NV, Bigot F, Boni V, Bowyer SE, Breder V, Cervantes A, Chan N, Cleary JM, Dhawan M, Eefsen RL, Ewing J, Graham DM, Guren TK, Won Kim J, Koynov K, Oh DY, Redman R, Yen CJ, Spetzler D, Roubaudi-Fraschini MC, Nicolas-Metral V, Ait-Sarkouh R, Zanna C, Ennaji A, Pokorska-Bocci A, Flaherty KT. Grivas P, et al. Among authors: oh dy. Clin Cancer Res. 2024 May 21. doi: 10.1158/1078-0432.CCR-24-0012. Online ahead of print. Clin Cancer Res. 2024. PMID: 38771739
3,883 results